Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or ...

Good morning, and welcome to the Kinaxis Inc. Fiscal 2025 Fourth Quarter and Year-end Results Conference Call. [Operator Instructions] I'd like to remind everyone that this call is being recorded ...

Interpreted] Good morning and welcome to this press conference. We will introduce the numbers for 2025, but we'll start off as usual with a little movie. Eric Trappier unveiled in the East, the first ...

The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial ...

The total lunar eclipse on Tuesday, March 3, will be visible across New York, Boston, Los Angeles, Denver, Chicago and Miami, but east coast viewers only get 20 to 30 minutes before moonset. Find your ...

The Takoma Park Community Center functions as the town’s beating heart, hosting an array of activities that range from ...

Investors don't read 40-page plans. Learn how to condense your vision, your traction and your ask into a winning narrative they'll actually engage with.

Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden ...